Key Findings
The North America apheresis market is projected to forecast a CAGR of 8.12% across the estimated years of 2021 to 2028. The region’s market growth is mainly credited to the rising rates of plasma exchange procedures, the access to well-developed medical infrastructure, and the increasing number of apheresis procedures.

Market Insights
The North America apheresis market growth is assessed through the analysis of Canada and the United States. While Canada experiences continual developments in neurology apheresis procedures, the country’s market for apheresis equipment is set to augment, owing to the increasing number of plasma exchange procedures. The nation has a well-established market, primarily accredited to the presence of the Canadian Apheresis Group (CAG). It actively works in nearly 40 apheresis units throughout 19 leading medical centers in Canada. Moreover, as per the CAG, over 10,000 plasma exchange procedures are conducted annually, through the use of crystalloids, albumin, and plasma, as replacement fluids. With over 10% of the plasma collected in the country being utilized, statistics indicate that the masses are becoming increasingly aware of the procedures available.
According to the Terry Fox Research Institute, in 2019, approximately 21,700 people were diagnosed with blood cancers in Canada. Although these cancers impact people of all ages, the survival rates predominantly rely on the type of blood cancer diagnosed. Besides, it is assessed that around 7,500 individuals in Canada die from blood cancers, thereby making them the third-leading reason for cancer-linked deaths in the country. Hence, such factors are expected to fuel the market growth in Canada over the forecasted years.

Competitive Insights
The prominent firms operating in the market are Terumo Corporation, B Braun Melsungen AG, Haemonetics Corporation, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments